Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Shanghai Heartcare Medical Technology Corp. Ltd. Class H ( (HK:6609) ) has provided an announcement.
Shanghai HeartCare Medical Technology Corporation Limited has scheduled an extraordinary general meeting and a class meeting of H shareholders for 16 January 2026 to consider, among other matters, the proposed issuance of domestic shares under a specific mandate and amendments to its articles of association. To determine eligibility to attend and vote at these meetings, the H share register will be closed from 13 to 16 January 2026, with no share transfers registered during this period, and shareholders must ensure relevant transfer documents are lodged with the company’s Hong Kong share registrar by 12 January 2026, underscoring the procedural steps ahead of a potentially significant capital and governance move for the company.
The most recent analyst rating on (HK:6609) stock is a Hold with a HK$47.00 price target. To see the full list of analyst forecasts on Shanghai Heartcare Medical Technology Corp. Ltd. Class H stock, see the HK:6609 Stock Forecast page.
More about Shanghai Heartcare Medical Technology Corp. Ltd. Class H
Shanghai HeartCare Medical Technology Corporation Limited is a China-incorporated medical technology company listed in Hong Kong, focusing on healthcare-related products and services. Its shares are traded as H shares on the Stock Exchange of Hong Kong under stock code 6609, and it operates under a joint stock structure with both domestic and H shareholders.
Average Trading Volume: 55,346
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.87B
See more data about 6609 stock on TipRanks’ Stock Analysis page.